Duration of untreated psychosis (DUP) and the course of schizophrenia in a 20-year follow-up study☆
Introduction
In recent years, the criterion of duration of untreated psychosis (DUP) has risen to prominence as one of the fundamental factors determining prognosis in the course of schizophrenia-related psychotic disorders. Two meta-analyses (Marshall et al., 2005, Perkins et al., 2005) describing the results of research into the correlation between DUP and the course of illness and treatment outcomes unequivocally indicate the existence of a positive correlation, confirmed primarily by the aggregate results of numerous short-term studies (involving up to 5 years of observation). The first of these meta-analyses (Marshall et al., 2005) indicates a positive correlation between longer DUP and worse treatment outcomes in terms of general functioning, positive symptoms, and quality of life, but not between longer DUP and negative symptoms or social functioning. The second meta-analysis (Perkins et al., 2005) demonstrates a positive correlation between shorter DUP and better response to treatment—lesser severity of general psychopathology, positive and negative symptoms, and better general functioning. A significant meta-analysis concerning the relationship between DUP and negative symptoms in the short and medium term was conducted by Boonstra et al. (2012) Contrary to previous reports, it shows that there is an association between those areas. Based on a review of studies from the years 1992–2009, Boonstra found that a shorter DUP is associated with lesser severity of negative symptoms in both short-term (1–2 years) and medium-term (5–8 years) studies. The decrease in the severity of negative symptoms was non-linear. A DUP shorter than 9 months markedly increased the chances of less severe negative symptoms in follow-ups.
Prospective studies which begin with the first episode of psychosis (FEP) and assess the effect of DUP on remote treatment outcomes (over 10 years) are rarer. Our study falls into this category. It is a prospective study beginning at the point of first psychiatric hospitalization (real time), and it is long-term in duration (as per McGlashan (1988)): running over 10 years). We shall make reference to other studies fulfilling the same criteria—by Helgason (1990), Huber (1997), Wiersma et al. (2000), Kua et al. (2003), Bottlender et al. (2003), Röpcke and Eggers (2005), Kinoshita et al. (2005), White et al. (2009), Shirvastava et al. (2010), Ichinose et al. (2010), and Cechnicki et al. (2010). In these studies, the period of observation ranges from 10 to 28 years. The results of most of these studies indicate the existence of a correlation between DUP and remote treatment outcomes, although several of them present disparate results.
Diverse criteria have been adopted to divide DUP into short- and long-term, and various definitions of the end of DUP (e.g. psychiatric hospitalization, making contact with a therapist, starting to take neuroleptics, etc.) have been offered. Some of the studies (Helgason, 1990, Huber, 1997; Bottlender et al., 2003) did not include any intermediate assessment points, which makes assessment of the dynamics of potential changes over time difficult. In the studies (Huber, 1997, Wiersma et al., 1998, Wiersma et al., 2000, Kua et al., 2003), DUP analysis is included as one of many aspects of long-term catamnestic study, and the assessment is usually restricted to the influence of DUP on clinical outcomes. In the wake of ambiguous results, answers to three questions remain unsettled. First, is there a correlation between DUP and long-term outcomes in both clinical and social functioning over the course of many years of illness (in our case, 20)? Second, does this relationship remain constant over the years, or do the differences between the short- and long-DUP subgroups tend to fluctuate over time? Third, is there a cut-off point enabling us to define a period of untreated psychosis beyond which the treatment outcomes for schizophrenic psychoses (schizophrenia) tend to deteriorate markedly, and if so, what is it?
Section snippets
Participants
Eighty patients hospitalized for the first time for schizophrenia agreed to participate. These participants were diagnosed according to the DSM III criteria and rediagnosed in accordance with DSM IV at their 12-year follow-up. The study began with two assessments, one at admission and the other at discharge from the index hospitalization. The subsequent assessments were conducted at the 3- (K3), 7- (K7), 12- (K12), and 20-year (K20) points following the index hospitalization. All of the
Results
In the first step, we analyzed the relationship between DUP and the dynamics of psychopathological symptoms as measured on the BPRS using ANOVA, and found no interaction effect, as the dynamics of the changes in both groups were quite similar. There was however one significant main effect of DUP: the subgroup with short DUP had a significantly lower level of psychopathological symptoms over the 20 years than the long-DUP subgroup. Results favoring the short DUP subgroup were obtained for
Discussion
In this discussion we will address the correlation between DUP and patients׳ clinical status and functioning, the dynamics of the observed phenomena, and use of intermediate assessment points, and assess the cut-off point for division of DUP into short- and long-term. The conclusions arising from our study are largely concordant with the results of the abovementioned meta-analyses (Marshall et al., 2005, Perkins et al., 2005). We confirmed the existence of a positive correlation between short
Acknowledgments
We wish to thank Mr. Konrad Wroński for his significant assistance with the preparation of this paper. This study was financed from Grant no. K/ZDS/001469 to Collegium Medicum, Jagiellonian University.
References (26)
- et al.
Duration of untreated psychosis and negative symptoms—a systematic review and meta-analysis of individual patient data
Schizophrenia Research
(2012) - et al.
The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia
Schizophrenia Research
(2003) - et al.
IRAOS: an instrument for the assessment of onset and early course of schizophrenia
Schizophrenia Research
(1992) The heterogenous course of schizophrenia
Schizophrenia Research
(1997)- et al.
Inconsistency in the relationship between duration of untreated psychosis (DUP) and negative symptoms: sorting out the problem of heterogeneity
Schizophrenia Research
(2007) - et al.
Remission in schizophrenia: proposed criteria and rationale for consensus
American Journal of Psychiatry
(2005) - et al.
Prospektywna ocena wpływu czasu nieleczonej psychozy na przebieg schizofrenii (a prospective assessment the influence of duration of untreated psychosis on the course of schizophrenia)
Psychiatria Polska
(2010) - et al.
Treatment costs and clinical outcome for first episode schizophrenia patients: a 3-year follow-up of the Swedish “Parachute Project” and two comparison groups
Acta Psychiatrica Scandinavica
(2006) Twenty years׳ follow-up of first psychiatric presentation for schizophrenia: what could have been prevented?
Acta Psychiatrica Scandinavica
(1990)- et al.
Nagasaki Schizophrenia Study: relationship between ultra long-term outcome (after 28 years) and duration of untreated psychosis
Acta Medica Nagasakiensia
(2010)
Nagasaki schizophrenia study: influence of the duration of untreated psychosis on long-term outcome
Acta Medica Nagasakiensia
A 20-year follow-up study on schizophrenia in Singapore
Acta Psychiatrica Scandinavica
Manual for the expanded brief psychiatric rating scale
Schizophrenia Bulletin
Cited by (42)
Empirical validity of Leonhard's psychoses: A long-term follow-up study of first-episode psychosis patients
2024, Schizophrenia ResearchDuration of untreated prodromal psychosis among individuals with clinical high risk for psychosis
2023, Psychiatry ResearchDeep learning model using retinal vascular images for classifying schizophrenia
2022, Schizophrenia ResearchCitation Excerpt :Diagnosing schizophrenia in community settings is difficult in the absence of a trained psychiatrist leads to delay in the initiation of treatment. As early diagnosis and prompt initiation of treatment is an important predictor of better prognosis (Cechnicki et al., 2014), biomarker that could aid the clinician in the diagnosis are need of the hour. Given its ease of acquisition, low cost, portability and non-invasiveness, retinal vascular imaging is ideal for application in community settings (Wilson et al., 2008).
Cognitive ability and metabolic physical health in first-episode psychosis
2021, Schizophrenia Research: CognitionEffect of delaying treatment of first-episode psychosis on symptoms and social outcomes: a longitudinal analysis and modelling study
2020, The Lancet PsychiatryCitation Excerpt :It remains unclear how treatment delay affects other symptoms or whether this curve reflects gradual deceleration14,15 or a rapid, stepwise shift at some point.5,13 Since long DUP predicts a range of harms,1–6 we hypothesised that untreated psychosis causes generalised treatment resistance by exacerbating underlying illness processes, and that this damage progresses faster in the early stages of illness, decelerating over time as it approaches a natural limit, consistent with some previous evidence.13–15 We also hypothesised that socially disruptive symptoms before presentation might have a confounding effect—ie, severe excitement, hostility, and dysfunction could alarm people experiencing symptoms, and those around them, and lead to earlier presentation, in keeping with the little existing evidence available.12,14,16
- ☆
This study was conducted by the Cracow Schizophrenia Research Group.